{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:21:05Z","timestamp":1794360065086,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.yexcr.2024.114382","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T03:43:03Z","timestamp":1734234183000},"page":"114382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["AZD1390, an Ataxia telangiectasia mutated inhibitor, enhances cisplatin mediated apoptosis in breast cancer cells"],"prefix":"10.1016","volume":"444","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7659-742X","authenticated-orcid":false,"given":"Deniz","family":"\u00d6zdemir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can Ali","family":"A\u011fca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2024.114382_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2024.114382_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103662","article-title":"Targeting ATM and ATR for cancer therapeutics: inhibitors in clinic","volume":"28","author":"Priya","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.yexcr.2024.114382_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2015.2","article-title":"DNA damage and the balance between survival and death in cancer biology","volume":"16","author":"Roos","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2024.114382_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol. Cell."},{"key":"10.1016\/j.yexcr.2024.114382_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-05228-y","article-title":"The therapeutic significance of mutational signatures from DNA repair deficiency in cancer","volume":"9","author":"Ma","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2024.114382_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2016.02.003","article-title":"DNA repair targeted therapy: the past or future of cancer treatment?","volume":"160","author":"Gavande","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2024.114382_bib7","first-page":"6","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.yexcr.2024.114382_bib8","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/emboj.2009.281","article-title":"Emerging common themes in regulation of PIKKs and PI3Ks","volume":"28","author":"Lempi\u00e4inen","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2024.114382_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.dnarep.2009.04.006","article-title":"Common mechanisms of PIKK regulation","volume":"8","author":"Lovejoy","year":"2009","journal-title":"DNA Repair"},{"key":"10.1016\/j.yexcr.2024.114382_bib10","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s12276-022-00863-4","article-title":"DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities","volume":"54","author":"Abuetabh","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.yexcr.2024.114382_bib11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/genes12060845","article-title":"ATM: main features, signaling pathways, and its diverse roles in DNA damage response, tumor suppression, and cancer development","volume":"12","author":"Phan","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.yexcr.2024.114382_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/genes12050727","article-title":"The ATM gene in breast cancer: its relevance in clinical practice","volume":"12","author":"Stucci","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.yexcr.2024.114382_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12885-020-07749-6","article-title":"The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis","volume":"21","author":"Moslemi","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2024.114382_bib14","article-title":"Breast cancer therapy: a mini review","volume":"1","author":"Anjum","year":"2017","journal-title":"MOJ Drug Des. Dev. Ther."},{"key":"10.1016\/j.yexcr.2024.114382_bib15","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1158\/0008-5472.CAN-16-3398","article-title":"ATM deficiency is associated with sensitivity to PARP1-and ATR inhibitors in lung adenocarcinoma","volume":"77","author":"Schmitt","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2024.114382_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12943-024-01933-z","article-title":"The DNA damage sensor ATM kinase interacts with the p53 mRNA and guides the DNA damage response pathway","volume":"23","author":"Karakostis","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2024.114382_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.629266","article-title":"DNA repair pathways in cancer therapy and resistance","volume":"11","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2024.114382_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1535-7163.MCT-08-1189","article-title":"The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt","volume":"9","author":"Li","year":"2010","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.yexcr.2024.114382_bib19","first-page":"1","article-title":"53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells","volume":"16","author":"Hong","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2024.114382_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106230","article-title":"Ataxia-telangiectasia mutated & ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancer","volume":"147","author":"Gulliver","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yexcr.2024.114382_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models","volume":"4","author":"Durant","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.yexcr.2024.114382_bib22","article-title":"MiR-26a promotes ovarian cancer proliferation and tumorigenesis","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2024.114382_bib23","first-page":"75","article-title":"PARP inhibitor re-sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis","volume":"19","author":"Wu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yexcr.2024.114382_bib24","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yexcr.2024.114382_bib25","first-page":"295","volume":"vol. 10","author":"\u00d6zdemir","year":"2021"},{"key":"10.1016\/j.yexcr.2024.114382_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0076-6879(95)60154-6","article-title":"[29] Mitochondrial membrane potential monitored by JC-1 dye","volume":"260","author":"Reers","year":"1995","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.yexcr.2024.114382_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","article-title":"Mitochondrial membrane potential","volume":"552","author":"Zorova","year":"2018","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.yexcr.2024.114382_bib28","article-title":"Evaluating in vitro DNA damage using comet assay","volume":"128","author":"Lu","year":"2017","journal-title":"JoVE Journal Vis. Exp."},{"key":"10.1016\/j.yexcr.2024.114382_bib29","first-page":"34","article-title":"KAN0438757: a novel PFKFB3 inhibitor that induces programmed cell death and suppresses cell migration IN NON-small cell lung carcinoma cells, biotechnol","volume":"16","author":"\u00d6zdemir","year":"2023","journal-title":"Acta"},{"key":"10.1016\/j.yexcr.2024.114382_bib30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/13880209.2018.1495748","article-title":"Dicranopteris linearis extract inhibits the proliferation of human breast cancer cell line (Mda-mb-231) via induction of s-phase arrest and apoptosis","volume":"56","author":"Baharuddin","year":"2018","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.yexcr.2024.114382_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/0471142727.mb2806s111","article-title":"Assaying cell cycle status using flow cytometry,\u201d","volume":"111","author":"Kim","year":"2015","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.yexcr.2024.114382_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202000441","article-title":"The effect of TIGAR knockdown on apoptotic and epithelial-mesenchymal markers expression in doxorubicin-resistant non-small cell lung cancer A549 cell lines","volume":"17","author":"Agca","year":"2020","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.yexcr.2024.114382_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.6061\/clinics\/2017(04)09","article-title":"Breast cancer screening in developing countries","volume":"72","author":"da Costa Vieira","year":"2017","journal-title":"Clinics"},{"key":"10.1016\/j.yexcr.2024.114382_bib34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbcan.2019.07.002","article-title":"Novel insights into breast cancer progression and metastasis: a multidisciplinary opportunity to transition from biology to clinical oncology","volume":"1872","author":"Scimeca","year":"2019","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"key":"10.1016\/j.yexcr.2024.114382_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/genes10020153","article-title":"Genetic epidemiology of breast cancer in Latin America","volume":"10","author":"Zavala","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.yexcr.2024.114382_bib36","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1158\/1078-0432.CCR-23-0290","article-title":"ATM-inhibitor AZD1390 is a radiosensitizer for breast cancer CNS metastasis","volume":"29","author":"Tew","year":"2023","journal-title":"Clin. cancer Res. an Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.yexcr.2024.114382_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13578-020-0376-x","article-title":"ATM, ATR and DNA-PKcs kinases\u2014the lessons from the mouse models: inhibition \u2260 deletion","volume":"10","author":"Menolfi","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.yexcr.2024.114382_bib38","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/nar\/gkz025","article-title":"A. Franchitto ATM pathway activation limits R-loop-associated genomic instability in Werner syndrome cells","volume":"47","author":"Marabitti","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2024.114382_bib39","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/sj.cdd.4400874","article-title":"ATM, a central controller of cellular responses to DNA damage","volume":"8","author":"Khanna","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2024.114382_bib40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1535-7163.MCT-21-0934","article-title":"A new class of selective ATM inhibitors as combination partners of DNA double-strand break inducing cancer therapies","volume":"21","author":"Zimmermann","year":"2022","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.yexcr.2024.114382_bib41","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012716","article-title":"A. Blaukat DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Mar\u00e9chal","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.yexcr.2024.114382_bib42","article-title":"CRISPR metabolic screen identifies ATM and KEAP1 as targetable genetic vulnerabilities in solid tumors","volume":"120","author":"Li","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2024.114382_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aan5598","article-title":"ATM directs DNA damage responses and proteostasis via genetically separable pathways","volume":"11","author":"Lee","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.yexcr.2024.114382_bib44","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1083\/jcb.201806197","article-title":"ATM is activated by ATP depletion and modulates mitochondrial function through NRF1","volume":"218","author":"Chow","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2024.114382_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000666","article-title":"A long noncoding RNA sensitizes genotoxic treatment by attenuating ATM activation and homologous recombination repair in cancers","volume":"18","author":"Zhao","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.yexcr.2024.114382_bib46","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.21873\/anticanres.15351","article-title":"DNA double-strand break signaling is a therapeutic target in head and neck cancer","volume":"41","author":"Wu","year":"2021","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexcr.2024.114382_bib47","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3390\/genes12101581","article-title":"Cell death and survival pathways involving ATM protein kinase","volume":"12","author":"Aki","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.yexcr.2024.114382_bib48","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","article-title":"ATM mutations in cancer: therapeutic implications","volume":"15","author":"Choi","year":"2016","journal-title":"Mol. Cancer Therapeut."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482724004737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482724004737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T11:01:07Z","timestamp":1737284467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482724004737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0014482724004737"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2024.114382","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AZD1390, an Ataxia telangiectasia mutated inhibitor, enhances cisplatin mediated apoptosis in breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2024.114382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114382"}}